Blood donor characteristics
| Donor . | Sex . | Race . | Age, y . | LTNP, y . | CD4, n . | CD4, % . | Viral load . | Treatment . | HLA-A . | HLA-B . | HLA-C . |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIV+ LTNP | |||||||||||
| HIV 1 | F | AA | 40 | 7 | 1171 | 38 | 470 | AZT (pregnancy in 1994) | 11, 29 | 39, 57 | 06, 07 |
| HIV 1b | F | AA | 44 | 11 | 562 | 27 | 296 | AZT (pregnancy in 1994) | 11, 29 | 39, 57 | 06, 07 |
| HIV 2 | M | H | 42 | 8 | 1172 | 32 | 59 | None | 02, 28 | ND | ND |
| HIV 3 | M | W | 49 | 13 | 1173 | 27 | 1253 | AZT for 2 months in 1994 | 30, 28 | 18, 65 | 08, 08 |
| HIV 4 | F | W | 55 | 12 | 1174 | 43 | <50 | None | 01, 24 | 51, 57 | ND |
| HIV 4b | F | W | 59 | 16 | 749 | 44 | <196 | None | 01, 24 | 51, 57 | ND |
| HIV 5 | M | AA | 45 | 10 | 705 | 29 | 1810 | None | 30, 34 | 14, 42 | 08, 17 |
| HIV 6 | F | AA | 38 | 15 | 553 | 33 | <50 | None | 11, 28 | 51, 58 | 10, 14 |
| HIV 7 | M | W | 47 | 5 | 845 | 39 | 184 | None | 02, 33 | 07, 65 | 07, 08 |
| HIV 8 | M | AA | 28 | 8 | 507 | 32 | <50 | None | 02, 03 | 07, 49 | ND |
| HIV− CMV IgG+ | |||||||||||
| CMV 1 | M | W | 56 | — | — | — | — | — | 02, 02 | 44, 57 | 05, 06 |
| CMV 2 | M | W | 55 | — | — | — | — | — | 02, 03 | 07, 49 | ND |
| CMV 3 | F | W | 44 | — | — | — | — | — | 01, 02 | 08, 44 | 04, 07 |
| CMV 4 | F | H | 44 | — | — | — | — | — | 02, 03 | 35, 51 | 04, 04 |
| CMV 5 | M | W | 55 | — | — | — | — | — | 02, 11 | 38, 51 | 03, 03 |
| Donor . | Sex . | Race . | Age, y . | LTNP, y . | CD4, n . | CD4, % . | Viral load . | Treatment . | HLA-A . | HLA-B . | HLA-C . |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIV+ LTNP | |||||||||||
| HIV 1 | F | AA | 40 | 7 | 1171 | 38 | 470 | AZT (pregnancy in 1994) | 11, 29 | 39, 57 | 06, 07 |
| HIV 1b | F | AA | 44 | 11 | 562 | 27 | 296 | AZT (pregnancy in 1994) | 11, 29 | 39, 57 | 06, 07 |
| HIV 2 | M | H | 42 | 8 | 1172 | 32 | 59 | None | 02, 28 | ND | ND |
| HIV 3 | M | W | 49 | 13 | 1173 | 27 | 1253 | AZT for 2 months in 1994 | 30, 28 | 18, 65 | 08, 08 |
| HIV 4 | F | W | 55 | 12 | 1174 | 43 | <50 | None | 01, 24 | 51, 57 | ND |
| HIV 4b | F | W | 59 | 16 | 749 | 44 | <196 | None | 01, 24 | 51, 57 | ND |
| HIV 5 | M | AA | 45 | 10 | 705 | 29 | 1810 | None | 30, 34 | 14, 42 | 08, 17 |
| HIV 6 | F | AA | 38 | 15 | 553 | 33 | <50 | None | 11, 28 | 51, 58 | 10, 14 |
| HIV 7 | M | W | 47 | 5 | 845 | 39 | 184 | None | 02, 33 | 07, 65 | 07, 08 |
| HIV 8 | M | AA | 28 | 8 | 507 | 32 | <50 | None | 02, 03 | 07, 49 | ND |
| HIV− CMV IgG+ | |||||||||||
| CMV 1 | M | W | 56 | — | — | — | — | — | 02, 02 | 44, 57 | 05, 06 |
| CMV 2 | M | W | 55 | — | — | — | — | — | 02, 03 | 07, 49 | ND |
| CMV 3 | F | W | 44 | — | — | — | — | — | 01, 02 | 08, 44 | 04, 07 |
| CMV 4 | F | H | 44 | — | — | — | — | — | 02, 03 | 35, 51 | 04, 04 |
| CMV 5 | M | W | 55 | — | — | — | — | — | 02, 11 | 38, 51 | 03, 03 |
LTNP indicates long-term nonprogressor; HLA, human leukocyte antigen; CMV, cytomegalovirus; AA, African American; AZT, azidothymidine; ND, not determined; W, white; and H, Hispanic.